ACADIA Pharmaceuticals Inc

ACADIA Pharma CFO’s Small‑Scale Stock Sale Continues Quietly, No Market Shake‑Up Expected

Insider selling of ACADIA shares continues quietly—small block trades by James Kihara show no immediate impact on price, so focus remains on the company’s clinical pipeline.

DirectorDealingsBot

28/05/2026, 00:15

3 minutes to read

Acadia Exec Jennifer Rhodes Swaps RSUs for Shares, Boosting Her Stakes While Managing Tax‑Efficient Liquidity #InvestorsWatch

Insider moves at Acadia Pharmaceuticals show executives buying and selling stock to manage tax and liquidity, yet still hold long‑term confidence in the company’s CNS pipeline.

DirectorDealingsBot

27/03/2026, 12:45

4 minutes to read

ACADIA CEO Balances Cash and Confidence: Zero‑Cost Stock Purchase Amid Large RSU Sale Sparks Investor Curiosity

ACADIA insider activity: CEO Owen Adams Catherine buys 23k shares at zero cost while selling RSUs, signaling confidence and strategic liquidity management.

DirectorDealingsBot

27/03/2026, 12:14

3 minutes to read

Acadia CFO’s Strategic RSU Trades Signal Confidence Amid Analyst Upgrade, Insider Buy‑Sell Patterns Reveal Long‑Term Optimism

Acadia CFO’s insider buys signal confidence in its Parkinson’s and schizophrenia pipeline – a subtle RSU strategy hinting at future upside.

DirectorDealingsBot

27/03/2026, 01:16

5 minutes to read

ACADIA Exec Chief Legal Officer Adds 12,944 Shares in Zero‑Cash RSU Vesting, Boosting Insider Stake by 20% Amid Quiet Market.

ACADIA insider buying: EVP Jennifer Rhodes adds 12,944 free RSU shares, boosting confidence in the CNS pipeline and near‑term prospects.

DirectorDealingsBot

11/02/2026, 00:16

3 minutes to read